Jump to content
  • We are now offering Remote Courses

    Equal benefits to our residential courses, without the travel.

    View Courses
  • eLearning Passport

    All our courses. 12 months access. One flat fee.

    More Information
  • #RQA2020 Virtual Conference - Early Bird Pricing Now Available

    More Information

EMA - Pharmaceuticals – safe and affordable medicines (new EU strategy)

23rd June 2020

We would like to inform you that the European Commission has launched an online public consultation on the Pharmaceutical Strategy for Europe. 

Coming in the wake of the COVID-19 pandemic, the Strategy, which will also inform the newly proposed EU4Health Programme and align with Horizon Europe for research and innovation, will aim to ensure Europe's supply of safe and affordable medicines to meet patients' needs and support the European pharmaceutical industry to remain an innovator and world leader. 

The consultation consists of questions, which will focus on key themes: strategic autonomy and manufacturing of medicines, access to affordable medicines, innovation, and environmental sustainability and health challenges. The aim of the consultation is to allow the public, experts and stakeholders to contribute and voice their opinion on the best ways to address pharmaceutical related issues in the EU. The results of the public consultation will contribute to the preparation, in the autumn, of the Pharmaceutical Strategy, which is expected to be adopted by the end of the year.

The consultation will run until 15 September 2020, and questions can be accessed on EUSurvey.

For more details, please consult the press release and consultation.

Back to Recent News